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Figure 1 Percentage of samples positive by ELISA for Brucella
for each month of the study. The overall percentage of ELISA-
positive samples in the study population was 4.4%.cost;8,9 in clinical practice, ELISA could be useful in screening
suspected brucellosis cases among low-incidence populations
and as a supplementary assay in endemic areas in cases of
high clinical suspicion.
In the study population, no information was obtained as to
the presence or absence of brucellosis risk factors or symp-
toms. The Rose-Bengal test-positive sample, with a 1:400 SAT
titer, was probably a case of acute or recent brucellosis. For
those women with titers 50—200 and a negative Rose-Bengal
test, clinical correlation would determine which had active
or recent disease, or asymptomatic exposure.
The Brucella antibody prevalence of 4.4% provides strong
evidence for the endemicity of brucellosis, and is similar to
that reported in neighboring regional countries.1,10 Since this
study, a Brucella control program was instigated, which
initially led to a decreased incidence in Israel, followed in
recent years by a renewed increase.3,4 This, combined with
our evidence of endemicity in a West Bank female popula-
tion, re-emphasizes the need for regional brucellosis control
programs. A high index of suspicion for brucellosis is in order
in the presence of appropriate risk factors.
The data included in this manuscript were presented as a
poster at the Israeli Society of Infectious Diseases annual
meeting, Mitzpe Ramon, Israel, June 2004.
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doi:10.1016/j.ijid.2006.08.002Tuberculosis of major salivary glands: report of
a 7-year experience in Tehran, Iran
Tuberculosis (TB) of major salivary glands (MSG) is a rare
clinical entity with less than 50 cases of parotid and about
five cases of submandibular gland involvement reported sofar.1—10 Herein, we report the prevalence of MSG tuberculosis
in our 7-year experience of MSG masses.
Between 1996 and 2003, a total of 164 patients (83 male,
81 female) were admitted to Imam Khomeini and Amiralam
hospitals, two referral centers in Tehran, Iran, with a diag-
nosis of MSG mass. The mean age of patients was 40.9 (range
4—85) years. Pleomorphic adenoma (the most common diag-
Letters to the Editor 369nosis) was demonstrated in 63 (38.4%) patients, followed by
sialoadenitis in 16 (9.8%) and mucoepidermoid carcinoma in
nine (5.5%) patients.
MSG tuberculosis was diagnosed in five (3%) patients by
either histopathologic study or mycobacterium tuberculosis
PCR.Theirmeanagewas37.4 (range25—49)years.All patients
were female and midwives. The involved MSG was the sub-
mandibular gland in four (80%) patients and the parotid gland
in only one (20%) patient. None of the patients had a past or
family history of TB. Physical examination was unremarkable
except for the presence of MSG masses. All patients received
standard anti-tuberculous chemotherapy for 8—12 months.
Iran is an endemic country for TB, so it is important to have
an estimate of TB prevalence in MSGmasses. To the best of our
knowledge, this is the first formal report in this regard. A
recent study in South Korea reported eight cases of MSG
tuberculosis among patients admitted at any of the three
tertiary referral centers in a period of 10 years.11 The parotid
and submandibular glands were involved in five (62.5%) and
three cases (37.5%), respectively. Another study found only
one case of salivary gland TB among 150 patients with salivary
gland disease in a 14-year experience in India.12 TB involve-
ment was located in a minor salivary gland in that study. In
another study of 155 salivary gland masses, 10 (6.4%) cases of
TB infection were found.13 A study in Turkey reported parotid
involvement of TB in six cases among 216 patients with a
parotid mass.14 Finally, in a 12-year study in China, nine
patients were reported to have suffered from tuberculosis
of the parotid glands.15 The prevalence of MSG tuberculosis in
our study is relatively similar to that in other reports fromAsia.
Considering the extremely rare event of tuberculous
involvement of the submandibular gland,3,4 our experience
is unusual in that 80% of our patients had their submandibular
glands involved. We doubt that this unusually high rate of
submandibular gland tuberculosis could be regarded as inci-
dental. However, we are at present unclear as to themechan-
ism of TB’s strong tendency to involve the submandibular
glands in our patients. Studies with larger sample sizes are
needed to clarify the significance of this finding.
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doi:10.1016/j.ijid.2006.09.006Clinical factors indicating the presence of
pyogenic liver abscess in community-acquired
Klebsiella pneumoniae bacteremia
Klebsiella pneumoniae is a leading cause of pyogenic liver
abscess (PLA) in some Asian countries,1—5 where one of the
most common sources of K. pneumoniae bacteremia is PLA.6—8PLA presents a diagnostic challenge, because half of all
patients show no specific symptoms or signs that direct atten-
tion to the liver. This study was conducted to identify clinical
and laboratory factors indicating the early diagnosis of PLA in
community-acquired K. pneumoniae bacteremia.
Patients at three hospitals in Korea, diagnosed with K.
pneumoniae bacteremia between January 2001 and Decem-
ber 2004, were retrospectively reviewed with regard to
